Literature DB >> 15888736

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of epithelial ovarian carcinoma.

P A Vasey1, J Herrstedt, S Jelic.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15888736     DOI： 10.1093/annonc/mdi823

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

1.  Nanoparticle-induced intraperitoneal hyperthermia and targeted photoablation in treating ovarian cancer.

Authors:  Chao-Chih Wu; Yuh-Cheng Yang; Yun-Ting Hsu; T-C Wu; Chien-Fu Hung; Jung-Tang Huang; Chih-Long Chang
Journal:  Oncotarget       Date:  2015-09-29

2.  Pressurized IntraPeritoneal Aerosol Chemotherapy vs. intravenous chemotherapy for unresectable peritoneal metastases secondary to platinum resistant ovarian cancer - study protocol for a randomized control trial.

Authors:  S P Somashekhar; K R Ashwin; Amit Rauthan; Kumar C Rohit
Journal:  Pleura Peritoneum       Date:  2019-03-26

3.  A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study.

Authors:  Dimitrios Bafaloukos; Helena Linardou; Gerasimos Aravantinos; Christos Papadimitriou; Aristotelis Bamias; George Fountzilas; Haralabos P Kalofonos; Paris Kosmidis; Eleni Timotheadou; Thomas Makatsoris; Epaminondas Samantas; Evangelos Briasoulis; Christos Christodoulou; Pavlos Papakostas; Dimitrios Pectasides; Athanasios M Dimopoulos
Journal:  BMC Med       Date:  2010-01-07       Impact factor: 8.775

4.  The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study.

Authors:  Mette S Tetsche; Claus Dethlefsen; Lars Pedersen; Henrik T Sorensen; Mette Norgaard
Journal:  BMC Cancer       Date:  2008-01-29       Impact factor: 4.430

5.  Optimal chemotherapy treatment for women with recurrent ovarian cancer.

Authors:  M Fung-Kee-Fung; T Oliver; L Elit; A Oza; H W Hirte; P Bryson
Journal:  Curr Oncol       Date:  2007-10       Impact factor: 3.677

6.  Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers.

Authors:  György Sölétormos; Michael J Duffy; Suher Othman Abu Hassan; René H M Verheijen; Bengt Tholander; Robert C Bast; Katja N Gaarenstroom; Catharine M Sturgeon; Johannes M Bonfrer; Per Hyltoft Petersen; Hugo Troonen; Gian CarloTorre; Jan Kanty Kulpa; Malgorzata K Tuxen; Raphael Molina
Journal:  Int J Gynecol Cancer       Date:  2016-01       Impact factor: 3.437
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.